Overview

Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA

Status:
Recruiting
Trial end date:
2024-08-16
Target enrollment:
Participant gender:
Summary
Our study aims to show that lack of antibiotic prophylaxis to those undergoing bladder Botox injections is not significantly inferior to administering prophylaxis. By proving this, we aim to decrease antibiotic use in this setting to combat the growing issue of antibiotic resistance. Participants will be randomized to antibiotic or no treatment arm. Those randomized to the treatment arm will receive oral antibiotics for 2 days pre-treatment, on the treatment day, and 2 days post-treatment. Patients will return for a follow up appointment approximately 2 weeks after treatment to assess for UTI symptoms. They will be called again at 6 weeks for follow up.
Phase:
Phase 4
Details
Lead Sponsor:
Atlantic Health System
Collaborator:
Columbia University
Treatments:
Amoxicillin-Potassium Clavulanate Combination
Cephalexin
Ciprofloxacin
Fosfomycin
Nitrofurantoin
Sulfamethoxazole
Trimethoprim